Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024
-
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results
-
Nano Dimension is Presenting at The ThinkEquity Conference on October 30th, 2024
-
Linklogis Releases Q3 Results: Transaction Volume Exceeds RMB100 Billion, Hitting a Record High
-
Clean Energy Technologies, Inc. and Exergy International Sign MOU to Promote ORC Heat Recovery Solutions Across the Americas
-
Allogene Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ALLO-316, an AlloCAR T™ Investigational Product for Adult Patients with Advanced or Metastatic Renal
-
BTQ Technologies Corp. to Present at the AI & Technology Virtual Investor Conference October 31st
-
Dremio Unveils Industry’s First Hybrid Data Catalog for Apache Iceberg, Delivers Unmatched Flexibility and Governance Across All Deployment Models
-
HeartCore to Appeal Nasdaq Delisting Notice
-
Cellebrite Announces Tim Tebow as Keynote Speaker for Inaugural Case-to-Closure (C2C) User Summit 2025
-
Blade Air Mobility Announces Opening of Investor Q&A Platform Ahead of its Release of Fiscal Third Quarter 2024 Financial Results
-
PodcastOne (PODC) Sets Network Launch of Gen Z Fave Pop Apologists Podcast
-
NEO Battery Materials Enters into Letter of Intent with Canadian Municipality for Commercial Facility Land Lease
-
TeraWulf Schedules Conference Call for Third Quarter 2024 Financial Results
-
Ethos Cannabis Launches Revamped “Feel Better Club” Rewards Program To Simplify Earnings and Point Redemption
-
Leading Fastener Distributor Chooses Bridgeline’s AI-Driven HawkSearch
-
Afarak Group: Production Report Q3 2024
-
NANO Nuclear Energy Scheduled to Present at the ThinkEquity Conference on October 30, 2024
-
Latitude Food Allergy Care Announces the Opening of its New San Ramon Clinic
-
Kepler Group Hires Industry Leader Chris O’Brien as EVP, Head of Client Solutions
-
Charlesbank Named to Inc.’s Annual Founder-Friendly Investors List
-
NAPC Defense and Lamperd Less Lethal form Partnership for Security Products Marketing in The USA and Worldwide
-
Bridger Aerospace Announces Schedule for its Third Quarter 2024 Earnings Release and Conference Call
-
NKGen Biotech Presents Phase 1/2a Troculeucel Data in Alzheimer’s Disease at the 17th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
-
Grace Expands Polypropylene Operating Capacity in India with Nayara Energy Limited
-
Goodfood and Michelin-recommended restaurant L’Abattoir launch new smash-hit exclusive meal-kits
-
Advanced Care Group Celebrates Successful Integration of New Staffing Solutions and Announces Further Expansion
-
Franklin Electric Reports Third Quarter 2024 Results
-
Seanergy Maritime Issues Statement on Court’s Dismissal of Economou’s Litigation
-
StoneX Announces Election Trading Partnership Between FOREX.com and Kalshi
-
IPG Photonics Announces Third Quarter 2024 Financial Results
-
IPG Photonics Announces Agreement to Acquire CleanLASER
-
Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution
-
Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference
-
Deutsche Aircraft showcases the efficient and profitable 40-seater D328eco™ regional turboprop at the 2024 ATAC Conference in Vancouver
-
JET Tools Protect Machines and Operators with the Launch of JET BLACK
-
ConnectWise Strengthens Cybersecurity Portfolio with SkyKick’s NIS2 Compliance and Cloud Security Alliance Certification
-
Quest Resource Holding Corporation to Report Third Quarter 2024 Financial Results and Host Earnings Call on November 7, 2024
-
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024
-
CervoMed to Deliver Oral Presentation at the 8th International Lewy Body Dementia Conference
-
Tonix Pharmaceuticals to Present at BIO-Europe® 2024
-
Starton Therapeutics Announces Notice of Allowance for U.S. Patent Application 17/518,930 “Continuous Delivery of Lenalidomide and Other Immunomodulatory Agents” Including Transdermal Administrati
-
Midaxo named a Leader in the IDC MarketScape: Worldwide Mergers and Acquisitions Software 2024 Vendor Assessment
-
NV5 to Host Third Quarter 2024 Conference Call on Thursday, November 7th at 4:30pm ET
-
Locus Unveils Refrigerant Management Software Aligned with the EPA’s Final Rule on Hydrofluorocarbon Phasedown
-
Crowdbotics Unveils Extension for GitHub Copilot to Help Developers Generate More Accurate Code
-
You Could Get Up to $1,300 the Same Day with an H&R Block Emerald Advance® Loan
-
Yoshitsu Co., Ltd Announces Opening of New “Reiwatakiya” Store in Fashion Show Las Vegas, Strengthening U.S. Market Presence
-
CALIFORNIA BANCORP REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2024
-
Tickets For 2025 Formula E Miami E-Prix on Sale Now

